K Number
K231341
Date Cleared
2023-08-14

(97 days)

Product Code
Regulation Number
884.5470
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The tampon is intended for insertion into the vagina for the absorption of menstrual or other vaginal discharge.

Device Description

The organic cotton tampon and viscose tampon are traditional unscented menstrual tampons. Except for the raw materials, they share the same design. The organic cotton tampon and viscose tampon, both have two types i.e., digital tampon and applicator tampon. The tampon applicator is available in two colors - milky and pink. Each device consists of a tampon, including an absorbent 100% organic cotton or 100% viscose pledget ("absorbent core") surrounded by polyethylene and polyethylene terephthalate overwrap ("security veil"), a 100% organic cotton or polyester and cotton removal string ("withdrawal cord"), and an applicator (only for the applicator tampon). The applicator is made of polyethylene and polypropylene. The tampon is of the traditional cylindrical, bullet-like shape. The applicator has a smooth, rounded tip to ease insertion. Both, organic cotton tampon and viscose tampon, are provided in 4 absorbencies: light (≤6g), regular (69g), super (912g) and super plus (12~15g). Each device is individually wrapped in a polyethylene/nonwoven laminated film or cellophane film and packaged in sealed multi-unit containers for retail sale. It is provided non-sterile and for single use only.

AI/ML Overview

The provided text is a 510(k) Summary for a medical device (tampon). It details performance testing, biocompatibility testing, and microbiology testing, but does not describe an AI/ML-based device or a study that uses AI/ML.

Therefore, I cannot provide the information requested in your prompt regarding acceptance criteria and studies that prove an AI device meets those criteria.

The information typically provided in such a document for a traditional medical device (like a tampon) focuses on demonstrating substantial equivalence to a predicate device through adherence to recognized standards and guidance, not on AI/ML performance metrics.

Specifically, the document states:

  • No AI: The device is an "Organic cotton tampon" and "Viscose tampon," with no mention of AI or machine learning.
  • No clinical study: "No clinical study is included in this submission."
  • Non-clinical testing only: The document summarizes "Non-clinical Testing" including performance, biocompatibility, and microbiology tests.

If you have a document describing an AI/ML medical device, please provide that, and I would be happy to analyze it according to your requested criteria.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

August 14, 2023

Zhejiang Tianqing Manufacturing Technology Group Co., Ltd. % Grace Liu Consultant Shenzhen Joyantech Consulting Co. Ltd 1713A, 17th Floor, Block A, Zhongguan Times Square, Nanshan District Shenzhen, Guangdong 518000 China

K231341 Re:

Trade/Device Name: Organic cotton tampon. Viscose tampon Regulation Number: 21 CFR§ 884.5470 Regulation Name: Unscented Menstrual Tampon Regulatory Class: II Product Code: HEB Dated: August 3, 2023 Received: August 3, 2023

Dear Grace Liu:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.

You must comply with all the Act's requirements. including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Reginald K. Avery -S

for

Jason R. Roberts, Ph.D. Assistant Director DHT3B: Division of Reproductive, Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K231341

Device Name

Organic cotton tampon, Viscose tampon

Indications for Use (Describe)

The tampon is intended for insertion into the absorption of menstrual or other vaginal discharge.

Type of Use (Select one or both, as applicable)
---------------------------------------------------

Prescription Use (Part 21 CFR 801 Subpart D)

|X | Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510(k) Summary - K231341

1. Contact Details

1.1 Applicant information

Applicant NameZhejiang Tianqing Manufacturing Technology Group Co., Ltd.
AddressLianshi Industrial Park, Nanxun District, Huzhou City, Zhejiang
Province, China
Websitewww.tianqingglobal.com
Contact personRoy Du
Phone No.+86-13817862379
E-mailroy.d@tianqingglobal.com
Date PreparedAugust 8, 2023

1.2 Submission Correspondent

Shenzhen Joyantech Consulting Co., Ltd
1713A, 17th Floor, Block A, Zhongguan Times Square, Nanshan
早远大成District, Shenzhen, Guangdong Province, China
Phone No.+86-755-86069197
Contact personGrace Liu, Field Fu
Contact person's e-mailgrace@cefda.com, field@cefda.com
Websitehttp://www.cefda.com

2. Device Information

Trade nameOrganic cotton tampon, Viscose tampon
Common nameUnscented Menstrual Tampon
ClassificationII
Classification nameTampon, Menstrual, Unscented
Product codeHEB
Regulation No.21 CFR 884.5470

3. Legally Marketed Predicate Device

Trade NameTosama 100% Organic Cotton Menstrual Tampon
510(k) NumberK151170
Product CodeHEB
ManufacturerTOSAMA, d.o.o.
Design Related RecallNone

4. Device Description

The organic cotton tampon and viscose tampon are traditional unscented menstrual tampons. Except for the raw materials, they share the same design. The organic cotton tampon and viscose tampon, both have two types i.e., digital tampon and applicator tampon. The tampon applicator is available in two colors - milky and pink. Each device consists of a tampon, including an absorbent 100% organic cotton or 100% viscose pledget ("absorbent core") surrounded by polyethylene and polyethylene terephthalate

{4}------------------------------------------------

overwrap ("security veil"), a 100% organic cotton or polyester and cotton removal string ("withdrawal cord"), and an applicator (only for the applicator tampon). The applicator is made of polyethylene and polypropylene. The tampon is of the traditional cylindrical, bullet-like shape. The applicator has a smooth, rounded tip to ease insertion.

Both, organic cotton tampon and viscose tampon, are provided in 4 absorbencies: light (≤6g), regular (69g), super (912g) and super plus (12~15g). Each device is individually wrapped in a polyethylene/nonwoven laminated film or cellophane film and packaged in sealed multi-unit containers for retail sale. It is provided non-sterile and for single use only.

5. Intended Use/Indication for Use

The tampon is intended for insertion into the vagina for the absorption of menstrual or other vaginal discharge.

6. Technological Characteristics Comparison

Comparison itemSubject Device (K231341)Predicate Device(K151170)Comment
ManufacturerZhejiang Tianqing ManufacturingTechnology Group Co., Ltd.TOSAMA, d.o.o.None
Product NameOrganic cottontamponViscosetamponTosama 100%Organic CottonMenstrualTamponNone
Product CodeHEBHEBSame
Regulation Number21 CFR § 884.547021 CFR § 884.5470Same
ClassificationClass IIClass IISame
Intended Use / Indications forUseThe tampon is intended for insertioninto the vagina for the absorption ofmenstrual or other vaginal discharge.The Tosoma 100%Organic CottonMenstrual Tampon isintended for insertioninto the vagina forthe absorption ofmenstrual or othervaginal discharge.Same
Single UseYesYesSame
SterilityNon-sterileNon-sterileSame
DesignTampon with cylindrical shape andbullet-like tip.Applicator with smooth, rounded tip.Tampon withcylindrical shape andbullet-like tip.Applicator withsmooth, rounded tip.Same
Absorbency
Light≤6gN/A
Regular6~9g6~9gDifferent
Super9~12g9~12g
Super plus12~15g12~15g
Product dimensions
Digital tampon
LightPledget length(43~49) mmN/A
Pledget diameter(9.5~12.5) mmN/A
Removal stringlength(120~160) mm
RegularPledget length(44~50) mm(43.0~46.0) mm
Pledget diameter(10.5~13.5) mm(11.0~12.0) mm
Removal stringlength(120~160) mm(130~160) mm
SuperPledget length(45~51) mm(48.0~51.0) mm
Pledget diameter(11.5~14.5) mm(12.0~13.0) mm
Removal stringlength(120~160) mm(130~160) mm
Super plusPledget length(45~51) mm(48.0~51.0) mm
Pledget diameter(12.5~15.5) mm(14.0~15.0) mm
Removal stringlength(120~160) mm(130~160) mmDifferent
Applicator tampon
Pledget length(43~49) mm
Pledget diameter(9.5~12.5) mm
Removal stringlength(120~160) mm
LightApplicator length130.1 mmN/A
Applicatordiameter15.2 mm
Pledget length(44~50) mm(43.0~46.0) mm
Pledget diameter(10.5~13.5) mm(11.0~12.0) mm
Removal stringlength(120~160) mm(130~160) mm
RegularApplicator length130.1 mm120 mm
Applicatordiameter15.2 mm13 mm
Pledget length(45~51) mm(43.0~46.0) mm
Pledget diameter(11.5~14.5) mm(12.0~13.0) mm
Removal stringlength(120~160) mm(130~160) mm
SuperApplicator length131.0 mm120 mm
Applicatordiameter16.7 mm16 mm
Super plusPledget length(45~51) mm(43.0~46.0) mm
Pledget diameter(12.5~15.5) mm(14.0~15.0) mm
Removal stringlength(120~160) mm(130~160) mm
Applicator length131.0 mm120 mm
Applicatordiameter16.7 mm18 mm
ComponentMaterialsPledget100% OrganicCotton100% Viscose100% OrganicCottonDifferent
OverwrapPolyethylene andPolyethyleneterephthalatePolyethylene andPolyethyleneterephthalate100% OrganicCotton
Removal string100% OrganicCottonPolyesterAndCotton100% Organic Cotton
ApplicatorPolyethyleneandPolypropylenePolyethyleneandPolypropyleneTPO
AdditivesandFinishingAgentsAnti-wicking agentof removal stringRepellan TRepellan T
Finishing agent ofpledgetFiber finishesFiber finishesNot available
Complies with ISO 10993-1YesYes
Compliance with microbiologyrequirements of FDA Guidancefor TamponsYesYes
LabelingComplied with 21 CFR part 801 andFDA Menstrual Tampons and PadguidanceComplied with 21CFR part 801 andFDA MenstrualTampons and PadsguidanceSame

Table 1 Technological Characteristics Comparison Table

{5}------------------------------------------------

{6}------------------------------------------------

The subject devices have the same indication for use as the predicate device; therefore, the subject device has the same intended use as the predicate device. The differences in technological characteristics between the subject and predicate devices, outlined in Table 1, do not raise different questions for safety and effectiveness.

7. Summary of Non-clinical Testing

Non-clinical testing was conducted to verify that the subject devices meet all design and performance specifications similarly to the predicate device. The following tests were conducted.

Performance Testing

The following performance characteristics were assessed on the organic cotton tampon and the viscose tampon in accordance with the FDA guidance document "Guidance for Industry and FDA Staff - Menstrual Tampons and Pads: Information for Premarket Notification Submissions (510(k)s)" issued on July 27, 2005.

  • Dimensions

  • Absorbency

  • Removal string strength

  • Fiber shedding

  • Tampon integrity

{7}------------------------------------------------

  • Chemical residues

Biocompatibility Testing

Biocompatibility studies were performed on the organic cotton tampon and the viscose tampon in accordance with the FDA guidance document "Guidance for Industry and Food and Drug Administration Staff - Use of International Standard ISO 10993-1, 'Biological Evaluation of Medical Devices - Part 1: Evaluation and testing within a risk management process" issued on September 4, 2020 as follows:

  • A In vitro cytotoxicity test per ISO 10993-5:2009
  • Skin sensitization test per ISO 10993-10:2021

  • Vaginal irritation test per ISO 10993-23:2021

  • A Acute systemic toxicity test per ISO 10993-11:2017 (tampon only)

All the above tests, except acute systemic toxicity, were performed on the applicator. The tampon and applicator were tested separately. The results demonstrated that the subject device is non-cytotoxic, non-irritating, non-sensitizing, and non-systemically toxic.

Microbiology Testing

Per the FDA guidance document "Guidance for Industry and FDA Staff - Menstrual Tampons and Pads: Information for Premarket Notification Submissions (510(k)s)" issued on July 27, 2005, the following microbiology testing was conducted on the highest absorbency of the final, finished form of the subject devices (i.e., the organic cotton tampon and the viscose tampon), and the test results showed that the subject devices do not:

  • enhance the growth of Staphylococcus aureus;

  • increase the production of Toxic Shock Syndrome Toxin-1 (TSST-1); and do not

  • alter the growth of normal vaginal microflora.

8. Clinical Testing

No clinical study is included in this submission.

9. Conclusions

The nonclinical tests demonstrate that the proposed device is as safe and effective as the legally marketed device (K151170). Therefore, the subject device is substantially equivalent to the predicate device.

§ 884.5470 Unscented menstrual tampon.

(a)
Identification. An unscented menstrual tampon is a device that is a plug made of cellulosic or synthetic material that is inserted into the vagina and used to absorb menstrual or other vaginal discharge. This generic type of device does not include menstrual tampons treated with scent (i.e., fragrance materials) or those with added antimicrobial agents or other drugs.(b)
Classification. Class II (performance standards).